<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2013</year>
	<month>12</month>
	<day>15</day>
</pubdate>
<volume>14</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>24551574</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Assessment of C-reactive Protein and C3 as Inflammatory Markers of Insulin Resistance in Women with Polycystic Ovary Syndrome: A Case-Control Study</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>Background: Polycystic ovary syndrome (PCOS), a common endocrine disorder, is associated with infertility, menstrual dysfunction, hirsutism and frequent miscarriages. Insulin resistance, as a major cause of PCOS, represents a disorder with increase in inflammatory markers and risk of type 2 diabetes.  We aimed to investigate whether inflammatory markers, including C-reactive protein and C3 (Complement), are related and altered in polycystic ovary syndrome.
Methods: A case-control study including forty-two women diagnosed with PCOS, according to Rotterdam criteria, and forty-two healthy controls, matched for body mass index (BMI) and age, was conducted in 2012. C-Reactive protein (CRP) and C3 were assessed as possible determinants of the homeostasis model assessment (HOMA) index. Independent-sample t-test was used to compare the means of the groups in age, BMI, C3, FBS and BS 2hpp (2 hr postprandial glucose) and for CRP, Fasting Insulin and 2 hr Plasma Insulin and HOMA index. Mann-Whitney test and Pearson correlation were used for analyzing the data. The p&lt;0.05 was considered as statistically significant.
Results: Levels of plasma CRP (p=0.039), 2 hr pp (p=0.045), Fasting Insulin (p=0.002), 2 hr Plasma Insulin (p=0.002) and HOMA index (p=0.002) were significantly higher in PCOS patients. But C3 was not significantly higher in cases (p=0.885). There was no significant correlation between C3 and CRP with HOMA index.
Conclusion: CRP increased significantly in patients with PCOS and was associated with insulin resistance, the most probable cause of PCOS. However, such an association was not found in C3.
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>C3, C-reactive protein, Insulin resistance, Polycystic ovary syndrome</keyword>
	<start_page>197</start_page>
	<end_page>202</end_page>
	<web_url>https://www.jri.ir/article/544</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/544.pdf</pdf_url>
	<author_list><author><first_name>Setareh</first_name><middle_name></middle_name><last_name>Dehdashtihaghighat</last_name><suffix></suffix><affiliation>Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa>Setareh</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>Dehdashtihaghighat </last_name_fa><suffix_fa></suffix_fa><email></email><code>1181</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Abolfazl</first_name><middle_name></middle_name><last_name>Mehdizadehkashi</last_name><suffix></suffix><affiliation>Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa>Abolfazl</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>Mehdizadehkashi</last_name_fa><suffix_fa></suffix_fa><email>amehdizadehkashi@yahoo.com</email><code>1182</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Amirmohsen</first_name><middle_name></middle_name><last_name>Arbabi</last_name><suffix></suffix><affiliation>Iran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa>Amirmohsen</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>Arbabi</last_name_fa><suffix_fa></suffix_fa><email></email><code>1183</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohadeseh</first_name><middle_name></middle_name><last_name>Pishgahroudsari</last_name><suffix></suffix><affiliation>Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa>Mohadeseh</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>Pishgahroudsari</last_name_fa><suffix_fa></suffix_fa><email></email><code>1184</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Shahla</first_name><middle_name></middle_name><last_name>Chaichian</last_name><suffix></suffix><affiliation>Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa>Shahla</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>Chaichian</last_name_fa><suffix_fa></suffix_fa><email></email><code>1185</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

